SCHEMBL6360748

SCHEMBL6360748

COc1ccc(C(=O)Nc2ccc(Br)cc2C(=O)O)cc1F

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C2 P52895 5/20 0.60
AKR1C1 Q04828 5/20 0.60
GPR35 Q9HC97 1/20 0.58
AKR1C4 P17516 2/20 0.57
AKR1C3 P42330 2/20 0.57
CHEK1 O14757 1/20 0.56
PIM1 P11309 1/20 0.56
MAPK8 P45983 1/20 0.56
CLK4 Q9HAZ1 1/20 0.56
LMNA P02545 2/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
ABL1 P00519 2/20 0.56
RIN1 Q13671 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
POLB P06746 1/20 0.55
KCNK2 O95069 1/20 0.55
KCNK10 P57789 1/20 0.55
HTT P42858 2/20 0.55
RAB9A P51151 2/20 0.55
MAPK1 P28482 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6349632 0.89 CHEK1 (0.70) AKR1C2AKR1C1GPR35AKR1C4AKR1C3
SCHEMBL6347855 0.85 AKR1C2 (0.72) AKR1C2AKR1C1AKR1C4AKR1C3ABL1
SCHEMBL6353191 0.84 LMNA (0.60) AKR1C2AKR1C1AKR1C4AKR1C3CHEK1
SCHEMBL15702354 0.84 ABL1 (0.79) AKR1C2AKR1C1AKR1C4AKR1C3CHEK1
SCHEMBL6351826 0.83 CHEK1 (0.53) AKR1C2AKR1C1GPR35AKR1C4AKR1C3
SCHEMBL6353682 0.82 AKR1C2 (0.71) AKR1C2AKR1C1LMNATDP1POLB
SCHEMBL6349404 0.81 LMNA (0.81) AKR1C2AKR1C1AKR1C4AKR1C3CHEK1
SCHEMBL6349859 0.81 MAPT (0.76) AKR1C2AKR1C1GPR35AKR1C4AKR1C3
SCHEMBL17166275 0.80 AKR1C2 (0.73) AKR1C2AKR1C1AKR1C4AKR1C3ABL1
SCHEMBL6350824 0.80 KCNK2 (0.62) AKR1C2AKR1C1AKR1C4AKR1C3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 AKR1C2 3012/4885AKR1C1 2615/4885GPR35 4501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.